Back
CVS Health Quote, Financials, Valuation and Earnings
Sponsored
CVS
Sponsored
Forget 99.987% of Stocks (Use This ONE Instead)
See how to make massive profits by abandoning 8,251 of the 8,252 publicly traded stocks!
Sell
32
CVS
CVS Health
Last Price:
65.68
Seasonality Move:
-1.23%
7 Day Trial
ALL ACCESS PASS
$
7
See What One Ticker... One Trade... EVERY WEEK...Can Do for YOU
Show me one ticker payouts.CVS Health Price Quote
$65.68
+0.01 (+0.78%)
(Updated: September 2, 2023 at 6:04 AM ET)
CVS Health Key Stats
Sell
32
CVS Health (CVS)
is a Sell
Day range:
$65.39 - $65.95
52-week range:
$64.62 - $104.83
Dividend yield:
3.6%
P/E ratio:
20.91
P/S ratio:
0.25
P/B ratio:
1.16%
Volume:
6.3M
Avg. volume:
9.5M
1-year change:
-34.28%
Market cap:
$84.3B
Revenue:
$322.5B
EPS:
$2.28
How Much Does CVS Health Make?
-
How Much Are CVS Health's Sales Annually?
CVS Revenues are $322.5B -
How Much Profit Does CVS Health's Make A Year?
CVS net income is $4.1B
Is CVS Health Growing As A Company?
-
What Is CVS Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is CVS Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.35%
CVS Health Stock Price Performance
-
Did CVS Health Stock Go Up Last Month?
CVS Health share price went down by -11.2% last month -
Did CVS's Share Price Rise Over The Last Year?
CVS share price fell by -34.28% over the past 1 year
What Is CVS Health 52-Week High & Low?
-
What Is CVS Health’s 52-Week High Share Price?
CVS Health has traded as high as $104.83 over the past 52 weeks -
What Is CVS Health’s 52-Week Low Share Price?
CVS Health has traded as low as $64.62 over the past 52 weeks
CVS Health Price To Free Cash Flow
-
Is CVS Health Stock Overvalued?
CVS Health is trading at a price to free cash flow ratio of 4.84 -
Is CVS Health Stock Undervalued?
CVS Health EV to Free Cash Flow ratio is 7.44 -
What Is CVS Health’s Price Earnings Growth Ratio?
CVS PEG ratio is 0.00 -
Is CVS Health Trading At A Premium To Earnings?
CVS Health EV to EBIT ratio is 20.26
Is It Risky To Buy CVS Health?
-
How Much Debt Does CVS Health Have?
Total long term debt quarterly is $63.8B -
How Much Cash Does CVS Health Have?
Cash and short term investments quarterly total is $16.9B -
What Is CVS Health’s Book Value Per Share?
Book value per share is 56.73
Is CVS Health Cash Flow Positive?
-
What Is CVS Cash Flow From Operations?
Cash flow from operations (TTM) is $20.5B -
What Is CVS Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $947M -
What Is CVS Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19.8B
CVS Health Return On Invested Capital
-
Is Management Doing A Good Job?
CVS return on invested capital is 2.27% -
What Is CVS Health Return On Assets?
ROA measures how assets are converting to revenues and is 1.24% -
What Is CVS Return On Equity?
ROE is a measure of profitability and is 4.05%
CVS Health Earnings Date & Stock Price
-
What Is CVS Health's Stock Price Today?
A single share of CVS can be purchased today for 65.67 -
What Is CVS Health’s Stock Symbol?
CVS Health trades on the S&P500 under the ticker symbol: CVS -
When Is CVS Health’s Next Earnings Date?
The next quarterly earnings date for CVS Health is scheduled on November 2, 2023 -
When Is CVS's next ex-dividend date?
CVS Health's next ex-dividend date is July 20, 2023 -
How To Buy CVS Health Stock?
You can buy CVS Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CVS Health Competitors
-
Who Are CVS Health's Competitors?
Below is a list of companies who compete with CVS Health or are related in some way:
CVS Health Dividend Yield
-
What Is CVS Dividend Yield?
CVS Health’s dividend yield currently is 3.6% -
What Is CVS Health’s Payout Ratio?
CVS Health’s payout ratio is 103.28% -
When Did CVS Health Last Pay A Dividend?
The latest dividend pay date is September 4, 2023 -
What Is CVS Health’s Dividend Per Share?
CVS Health pays a dividend of $0.61 per share
CVS Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -35.37% | 4.23% |
Revenue: | 10.28% | 2.77% |
Analyst Recommendations
Buy Recommendations: | 13 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 92.31 |
Upside from Last Price: | 40.56% |